MediKarma Introduces First Ever Agentic AI Licensing Model for Disease Management

MediKarma, a leader in Agentic AI for healthcare, has launched what it describes as healthcare’s first Agentic AI Licensing Program, designed to give providers and partners access to pre-validated AI agents focused on disease management. The model allows healthcare organizations to license individual agents tailored to specific conditions, rather than building or training systems from scratch. MediKarma's agents are designed to support care coordination, patient engagement and longitudinal disease monitoring while operating within defined clinical and governance boundaries.

The announcement comes as healthcare systems explore how to operationalize AI beyond pilots while maintaining safety, compliance, and clinical trust. Members can choose between two agents: Jack AI, a universal enterprise engine that is designed to solve the industry's data fragmentation issue or Jill AI, which provides health-related agents on demand for distinct wellness issues. MediKarma’s approach reflects growing interest in treating AI agents as regulated digital assets, which could enable faster adoption while reducing development risk for providers navigating complex regulatory environments towards the next generation of digital health.

Posted by MedCloudInsider Editors on 01/12/2026